
|Articles|April 8, 2008
Fosrenol initiative launched by Shire for chronic kidney disease patients
Shire launches initiative for chronic kidney disease patients.
Advertisement
Shire Pharmaceuticals has launched
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































